Drug intelligence / Profile preview

curcuma longa extract

Development stage
Phase 3
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Curcuma longa extract is a botanical preparation derived from the rhizome of Curcuma longa (turmeric), a plant in the Zingiberaceae family. It contains a complex mixture of bioactive compounds, primarily curcuminoids (including curcumin), turmerone oil, glycosides, terpenoids, and flavonoids[1][3][5]. The extract is widely recognized for its **antioxidant, anti-inflammatory, immunomodulatory, neuroprotective, anticancer, hepatoprotective, cardioprotective, antimicrobial, and antidiabetic** properties[1][3][4][6]. Its mechanism of action is polypharmacological and includes inhibition of nuclear factor NF-κB, modulation of cytokine production (TNF-α, IL-1β, IL-6), inhibition of prostaglandin synthesis, scavenging of reactive oxygen species, and activation of peroxisome proliferator-activated receptor gamma (PPAR-γ)[1][3]. Curcuma longa extract is used in traditional medicine systems for the treatment of inflammatory conditions, digestive disorders (IBS, dyspepsia, ulcerative colitis), arthritis, metabolic syndrome, diabetes, cancer adjunctive therapy, liver diseases, and skin health[1][3][4][5][6]. It is commonly formulated as a dietary supplement (capsules, tablets, teas), as a culinary spice, or for topical use in skin conditions[2][3]. Poor oral bioavailability limits its systemic therapeutic effects, prompting the development of enhanced formulations and adjunct therapies[3]. Curcuma longa extract is certified as “generally recognized as safe” by the FDA for oral use[1].

Brand names
Turmipure GOLDArantalNovasolMerivaC3 complexC-3 complexC 3 complex
Other names
turmeric extractturmeric root extractCurcuma longaturmericIndian saffron
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)MEKPTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)NF-κBPPARG (Peroxisome proliferator-activated receptor gamma)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on curcuma longa extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on curcuma longa extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call